Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group, on; Russell‐Jones, David; Vaag, Allan; Schmitz, O.; Sethi, Bipin; Lalić, Nebojša; Antić, Slobodan; Zdravković, Marija; Martinez Ravn, Gabriela; Simó, Rafael

doi:10.1007/s00125-009-1472-y

Public

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Published in Diabetologia • Aug 13, 2009

Authors:

on behalf of the Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group

David Russell‐Jones

Allan Vaag

Abstract

AIMS/HYPOTHESIS: The aim of the study was to compare the efficacy and safety of liraglutide in type 2 diabetes mellitus vs placebo and insulin glargine (A21Gly,B31Arg,B32Arg human insulin), all in combination with metformin and glimepiride. METHODS: This randomised (using a telephone or web-based ra...

Subject

Medicine

Metformin

Sulfonylurea

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!